If you follow the latest technology and medical advancements of heart valve surgery, I thought you would enjoy this update and video:

Evalve, Inc., a leading provider of minimally invasive mitral valve repair techniques ^[1], has completed randomized enrollment in the endovascular valve edge-to-edge repair study, which is evaluating the MitraClip system as a non-surgical repair option for patients suffering from mitral regurgitation ^[2]. This study is an FDA-approved Phase II randomized, controlled, multi-center clinical research study in the US and Canada evaluating the safety and efficacy of the MitraClip device in 279 patients with moderate-to-severe mitral regurgitation.

Donald Glower, professor of surgery at Duke Medical Center and co-principal investigator of the Everest study, said: “This trial sets a high scientific standard for future mitral percutaneous valve therapies ^[3]. As a result, this trial will have a significant and long-lasting impact on patient care around the world.”

Keep on tickin!